Jundishapur Journal of Microbiology

Published by: Kowsar

Stenotrophomonas maltophilia Infections in Adults: Primary Bacteremia and Pneumonia

Mustafa Gokhan Gozel 1 , * , Cem Celik 2 and Nazif Elaldi 1
Authors Information
1 Department of Infectious Diseases and Clinical Microbiology, Cumhuriyet University Education and Research Hospital, Sivas, Turkey
2 Department of Medical Microbiology, Cumhuriyet University Education and Research Hospital, Sivas, Turkey
Article information
  • Jundishapur Journal of Microbiology: August 01, 2015, 8 (8); e23569
  • Published Online: August 22, 2015
  • Article Type: Research Article
  • Received: September 12, 2014
  • Accepted: January 6, 2015
  • DOI: 10.5812/jjm.23569

To Cite: Gokhan Gozel M, Celik C, Elaldi N. Stenotrophomonas maltophilia Infections in Adults: Primary Bacteremia and Pneumonia, Jundishapur J Microbiol. 2015 ; 8(8):e23569. doi: 10.5812/jjm.23569.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnote
References
  • 1. Tan CK, Liaw SJ, Yu CJ, Teng LJ, Hsueh PR. Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes. Diagn Microbiol Infect Dis. 2008; 60(2): 205-10[DOI][PubMed]
  • 2. Paez JI, Costa SF. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect. 2008; 70(2): 101-8[DOI][PubMed]
  • 3. Samonis G, Karageorgopoulos DE, Maraki S, Levis P, Dimopoulou D, Spernovasilis NA, et al. Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One. 2012; 7(5)[DOI][PubMed]
  • 4. Tseng CC, Fang WF, Huang KT, Chang PW, Tu ML, Shiang YP, et al. Risk factors for mortality in patients with nosocomial Stenotrophomonas maltophilia pneumonia. Infect Control Hosp Epidemiol. 2009; 30(12): 1193-202[DOI][PubMed]
  • 5. Wang WS, Liu CP, Lee CM, Huang FY. Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan. J Microbiol Immunol Infect. 2004; 37(6): 359-65[PubMed]
  • 6. Chung HS, Hong SG, Lee Y, Kim M, Yong D, Jeong SH, et al. Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from a Korean tertiary care hospital. Yonsei Med J. 2012; 53(2): 439-41[DOI][PubMed]
  • 7. Morata L, Cobos-Trigueros N, Martinez JA, Soriano A, Almela M, Marco F, et al. Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother. 2012; 56(9): 4833-7[DOI][PubMed]
  • 8. Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis. 2002; 34(12): 1653-6[DOI][PubMed]
  • 9. Park YS, Kim SY, Park SY, Kang JH, Lee HS, Seo YH, et al. Pseudooutbreak of Stenotrophomonas maltophilia bacteremia in a general ward. Am J Infect Control. 2008; 36(1): 29-32[DOI][PubMed]
  • 10. Safdar A, Rolston KV. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis. 2007; 45(12): 1602-9[DOI][PubMed]
  • 11. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988; 16(3): 128-40[DOI]
  • 12. Clinical and Laboratory Standards Institute . performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. 2008;
  • 13. Hanes SD, Demirkan K, Tolley E, Boucher BA, Croce MA, Wood GC, et al. Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin Infect Dis. 2002; 35(3): 228-35[DOI][PubMed]
  • 14. Maningo E, Watanakunakorn C. Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. J Infect. 1995; 31(2): 89-92[PubMed]
  • 15. Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad ,I, Safdar A. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004. Eur J Clin Microbiol Infect Dis. 2007; 26(1): 13-20[DOI][PubMed]
  • 16. Muder RR, Harris AP, Muller S, Edmond M, Chow JW, Papadakis K, et al. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis. 1996; 22(3): 508-12[PubMed]
  • 17. Cherif H, Kronvall G, Bjorkholm M, Kalin M. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. Hematol J. 2003; 4(6): 420-6[DOI][PubMed]
  • 18. Chang YT, Lin CY, Lu PL, Lai CC, Chen TC, Chen CY, et al. Stenotrophomonas maltophilia bloodstream infection: comparison between community-onset and hospital-acquired infections. J Microbiol Immunol Infect. 2014; 47(1): 28-35[DOI][PubMed]
  • 19. Falagas ME, Kastoris AC, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Dimopoulos G. Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol. 2009; 4(9): 1103-9[DOI][PubMed]
  • 20. Araoka H, Baba M, Yoneyama A. Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009. Eur J Clin Microbiol Infect Dis. 2010; 29(5): 605-8[DOI][PubMed]
  • 21. Lai CH, Chi CY, Chen HP, Chen TL, Lai CJ, Fung CP, et al. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect. 2004; 37(6): 350-8[PubMed]
  • 22. Boktour M, Hanna H, Ansari S, Bahna B, Hachem R, Tarrand J, et al. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients. Cancer. 2006; 106(9): 1967-73[DOI][PubMed]
  • 23. Guyot A, Turton JF, Garner D. Outbreak of Stenotrophomonas maltophilia on an intensive care unit. J Hosp Infect. 2013; 85(4): 303-7[DOI][PubMed]
  • 24. Apisarnthanarak A, Mayfield JL, Garison T, McLendon PM, DiPersio JF, Fraser VJ, et al. Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study. Infect Control Hosp Epidemiol. 2003; 24(4): 269-74[DOI][PubMed]
  • 25. Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012; 25(1): 2-41[DOI][PubMed]
  • 26. Looney WJ, Narita M, Muhlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis. 2009; 9(5): 312-23[DOI][PubMed]
  • 27. Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy LM. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study. Am J Infect Control. 2007; 35(9): 606-12[DOI][PubMed]
  • 28. Oteo J, Perez-Vazquez M, Campos J. Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis. 2010; 23(4): 320-6[PubMed]
  • 29. Weber DJ, Rutala WA, Sickbert-Bennett EE, Samsa GP, Brown V, Niederman MS. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol. 2007; 28(7): 825-31[DOI][PubMed]
  • 30. Paez JI, Tengan FM, Barone AA, Levin AS, Costa SF. Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis. 2008; 27(10): 901-6[DOI][PubMed]
  • 31. Araoka H, Fujii T, Izutsu K, Kimura M, Nishida A, Ishiwata K, et al. Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy. Transpl Infect Dis. 2012; 14(4): 355-63[DOI][PubMed]
  • 32. Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis. 2010; 51 Suppl 1-7[DOI][PubMed]
  • 33. Korvick JA, Bryan CS, Farber B, Beam TJ, Schenfeld L, Muder RR, et al. Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother. 1992; 36(12): 2639-44[PubMed]
  • 34. Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S, et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis. 2000; 31(3): 705-11[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments